As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State
暂无分享,去创建一个
M. Kulldorff | Sunetra Gupta | E. Ooi | Danielle E. Anderson | D. Rhoads | Melissa B. Miller | Hyukmin Lee | Krajden Mel | D. Anderson | Melissa B. Miller
[1] M. Emamian,et al. Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies , 2022, Current Microbiology.
[2] Our world in data , 2022 .
[3] R. Peeling,et al. Diagnostics for COVID-19: moving from pandemic response to control , 2021, The Lancet.
[4] C. del Rio,et al. SARS-CoV-2 Testing Before International Airline Travel, December 2020 to May 2021 , 2021, Mayo Clinic Proceedings.
[5] R. Neher,et al. Novel SARS-CoV-2 variants: the pandemics within the pandemic , 2021, Clinical Microbiology and Infection.
[6] Nicky Phillips,et al. The coronavirus is here to stay — here’s what that means , 2021, Nature.
[7] J. Tate,et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[8] P. Serón,et al. Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance , 2021, BMJ Open.
[9] S. Fontana,et al. Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting. , 2020, The Journal of infectious diseases.
[10] Mary D. Fortune,et al. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting , 2020, Clinical Microbiology and Infection.
[11] K. Jayatilleke. Challenges in Implementing Surveillance Tools of High-Income Countries (HICs) in Low Middle Income Countries (LMICs) , 2020, Current Treatment Options in Infectious Diseases.
[12] Savannah L. Bergquist,et al. COVID-19 pandemic in the United States , 2020, Health Policy and Technology.